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Abstract
Amylofeed® is a feed additive that contains glucanase, xylanase and amylase activities, and it is intended
to be used as a zootechnical additive for weaned piglets and minor porcine species. In previous
assessments, the additive was characterised and the safety for the target species, consumers and
environment was established. Considering the safety for the user, the EFSA Panel on Additives and
Products or Substances used in Animal Feed (FEEDAP) concluded that the additive should be considered
as a potential skin and eye irritant and a potential skin and respiratory sensitiser. Furthermore, the
Panel concluded that the additive has a potential to be efﬁcacious in the target species. However,
the efﬁcacy at the recommended enzyme activities could not be established. In order to overcome this
limitation, the applicant proposed to modify the speciﬁcations of the additive whilst keeping the
recommended level of addition of 500 mg additive/kg feed. The Panel evaluated the new speciﬁcations
and their impact on the relevant aspects of the safety and efﬁcacy of the additive. The newly proposed
speciﬁcations of the additive were supported by analytical data. The Panel considered that the
modiﬁcation proposed by the applicant on the speciﬁcations would not have an impact on the safety
aspects related to the consumer, user and environment. Therefore, the conclusions previously drawn
would still apply. Moreover, it was considered that the tolerance trial previously evaluated would still
support the safety for the target species. The addition of the additive with the new speciﬁcations would
result in higher enzyme activities than those that were found in the efﬁcacy studies that supported the
efﬁcacy of the product. Therefore, the additive has the potential to be efﬁcacious at the newly proposed
level of enzyme activities.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Regulation (EC) No 1831/2003 establishes rules governing the Community authorisation of additives
for animal nutrition and, in particular, Article 9 deﬁnes the terms of the authorisation by the Commission.
The applicant, Andres Pintaluba S.A., is seeking a Community authorisation of endo-1,3(4)-beta-
glucanase EC 3.2.1.6, endo-1,4-beta-xylanase EC 3.2.1.8 & alpha-amylase EC 3.2.1.1 to be used as a
zootechnical additive for piglets (weaned) and young minor porcine species (Table 1).
On 16 May 2017, the Panel on Additives and Products or Substances used in Animal Feed of the
European Food Safety Authority (“Authority”), in its opinion on the safety and efﬁcacy of the product, was
not in a position to conclude on the efﬁcacy at the recommended dose in terms of enzyme activity.
The Commission gave the possibility to the applicant to submit complementary information in order
to complete the assessment and to allow a revision of Authority’s opinion. The new data have been
sent to the Commission and the EFSA on 31 October 2017.
In view of the above, the Commission asks the Authority to deliver a new opinion for endo-1,3(4)-
beta-glucanase EC 3.2.1.6, endo-1,4-beta-xylanase EC 3.2.1.8 & alpha-amylase EC 3.2.1.1 to be used
as a zootechnical additives for piglets (weaned) and young minor porcine species based on the
additional data submitted by the applicant.
1.2. Additional information
Amylofeed® is a product authorised as a zootechnical additive for weaned piglets that was subject
to re-evaluation. EFSA performed the re-evaluation of the additive and released two opinions (EFSA
FEEDAP Panel, 2013, 2017). In those opinions the additive was characterised and the safety for the
target species, consumers and environment were established. However, the efﬁcacy in terms of
recommended enzyme activities could not be established because in three out of four studies
glucanase and xylanase activities were higher than the ones resulting from the addition of 500 mg
additive/kg feed considering the minimum speciﬁcations of enzyme activities.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of Supplementary
information1 following two previous applications on the same product.2
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and efﬁcacy of Amylofeed®
(endo-1,3(4)-b-glucanase, endo-1,4-b-xylanase and a-amylase) is in line with the principles laid down
in Regulation (EC) No 429/2008 and the relevant guidance documents: Guidance on zootechnical
additives (EFSA FEEDAP Panel, 2012), Technical guidance: Tolerance and efﬁcacy studies in target
animals (EFSA FEEDAP Panel, 2011) and Technical Guidance: Extrapolation of data from major species
to minor species regarding the assessment of additives for use in animal nutrition (EFSA, 2008).
Table 1: Description of the substances
Category of additive Zootechnical additives
Functional group of additive Digestibility enhancers
Description Endo-1,3(4)-beta-glucanase EC 3.2.1.6, endo-1,4-beta-xylanase
EC 3.2.1.8 & alpha-amylase EC 3.2.1.1
Target animal category Piglets (weaned) and young minor porcine species
Applicant Andres Pintaluba S.A.
Type of request New opinion
1 FAD-2017-0063.
2 FAD-2010-0353 and FAD-2014-0019.
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3. Assessment
Amylofeed® is a feed additive that contains, endo-1,3(4)-b-glucanase (glucanase; Enzyme
commission number (EC) 3.2.1.6), endo-1,4-b-xylanase (xylanase; EC 3.2.1.8) and a-amylase (amylase;
EC 3.2.1.1). The additive is to be used as a zootechnical additive (functional group: digestibility
enhancers) for weaned piglets and minor porcine species.
In previous assessments (EFSA FEEDAP Panel, 2013, 2017), the additive was characterised and the
safety for the target species, consumers and environment was established. Considering the safety for the
user, the Panel concluded that the additive should be considered as a potential skin and eye irritant and a
potential skin and respiratory sensitiser. In 2017, the Panel also concluded that the additive has a
potential to be efﬁcacious in weaned piglets and minor young porcine species at a nominal level of
inclusion (500 mg additive/kg feed). However, the efﬁcacy at the recommended enzyme activities could
not be established.
For enzymes, the efﬁcacious level of the additive in feed should be established according to the
enzyme activity administered to the animals. The additive characterised in previous opinions (EFSA
FEEDAP Panel, 2013, 2017) contained per gram of product a minimum activity of 275 Units (U)3 of endo-
1,3(4)-b-glucanase (glucanase), 400 U4 of endo-1,4-b-xylanase (xylanase) and 3,100 U5 of a-amylase
(amylase). In the conditions of use, the applicant proposed to add this additive in feed at the level of
500 mg/kg feed. Considering the minimum speciﬁcations of the additive, 500 mg additive/kg feed would
deliver an enzyme activity (in U/kg feed) of 138 for glucanase, 200 for xylanase and 1,550 for amylase. In
the four efﬁcacy studies assessed, the additive was added at the level of 500 mg additive/kg feed. The
analytical data of the feed used in those studies showed overages in glucanase and xylanase enzyme
activities in three of the trials (trials 2–4, see Table 2). For glucanase, the overage ranged from 2.5 to 4.5
times the intended enzyme activity, for xylanase from 2.5 to 3.6. This was the result of overages in
glucanase and xylanase activities in the batches of the additive used to prepare the feed offered to the
animals.
The applicant has proposed to modify the speciﬁcations of the additive in terms of minimum
enzyme activity. The applicant wishes to increase the minimum glucanase and xylanase activities while
keeping the same level of addition in feed of 500 mg additive/kg feed. This modiﬁcation would permit
to achieve higher glucanase and xylanase activities in feed; activities that would be more in line with
the ones found in the feeds used in the efﬁcacy trials.
The Panel evaluated this modiﬁcation and the impact on the relevant aspects of the safety and
efﬁcacy of the additive.
Table 2: Intended and analysed enzyme activities (U/kg feed) in the feeds used in the four efﬁcacy
trials in weaned piglets
Trial
Glucanase Xylanase Amylase
Intended Analysed Intended Analysed Intended Analysed
1(a) 138 281 200 160 1,550 1,091
2(b) 138 620 200 562 1,550 1,872
3(c) 138 378 200 507 1,550 1,056
4(d) 138 338 200 719 1,550 1,542
Average 404 487 1,390
(a): Technical dossier FAD-2014-0019/Annex IV.3.1.
(b): Technical dossier FAD-2014-0019/Supplementary information December 2015/Annex IV.3.7.
(c): Technical dossier FAD-2014-0019/Supplementary information November 2016/Annex IV.3.8.
(d): Technical dossier FAD-2014-0019/Supplementary information January 2017/Annex IV.3.9.
3 1 U is the amount of enzyme that liberates 1 micromole of reducing sugars (glucose equivalents) from oat b-glucan per minute
at pH 4.0 and 30°C.
4 1 U is the amount of enzyme that liberates 1 micromole of reducing sugars (glucose equivalents) from rye arabinoxylan per
minute at pH 4.0 and 30°C.
5 1 U is the amount of enzyme that liberates 1 micromole of reducing sugars (glucose equivalents) from wheat starch per minute
at pH 5.0 and 30°C.
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3.1. Characterisation
The new speciﬁcations of the additive in terms of minimum enzyme activities (U/g additive) are as
follows: 900 U glucanase, 1,000 U xylanase and 3,000 U of amylase. The applicant provided data of
ﬁve batches of the additive supporting the new speciﬁcations.6 Mean glucanase activity was 1,177 U/g
(range 1,001–1,404 U/g, coefﬁcient of variation (CV) 15%), mean xylanase activity was 1,306 U/g
(range 1,161–1,450, CV 10%) and mean amylase activity was 5,438 U/g (range 4,314–6,513 U/g, CV
of 17%). According to the applicant, this higher enzyme activities could be reached without modifying
the manufacturing of the enzymes/additive.
The additive is intended to be used at the level of 500 mg additive/kg feed. Considering the new
speciﬁcations the addition of 500 mg additive/kg feed would result in 450 U of glucanase, 500 U of
xylanase and 1,500 U of amylase per kg feed.
3.2. Safety
In previous assessments, the FEEDAP Panel concluded that the additive is safe for the target
species, for the consumers and environment. The Panel also concluded that the additive is a potential
skin and eye irritant and a potential skin and respiratory sensitiser.
The Panel considers that the modiﬁcation proposed by the applicant on the speciﬁcations of the
additive would not have an impact on the safety aspects related to the consumer, user and
environment. Therefore, the conclusions previously drawn would still apply to the additive compliant
with the new speciﬁcations. However, the new speciﬁcations of the additive will result in a higher
enzyme activity in the feed and therefore the safety for the target species requires consideration.
In 2013, the FEEDAP Panel evaluated a tolerance study in weaned piglets. The Panel concluded
that the additive is safe for weaned piglets and the conclusions were extrapolated to minor porcine
species (except breeding animals). In that study, three groups were considered: no additive, additive
supplemented at the proposed dose and 100-fold the proposed dose. The comparison of the enzyme
activities measured in the feeds offered to the piglets and those that would result from the use of the
new additive showed that the feeds prepared as a 100-fold would represent 73-fold the new glucanase
activity level (450 U/kg feed), 75-fold the new xylanase activity level (500 U/kg feed) and 115-fold the
new amylase activity (1,500 U/kg feed). The parameters measured during the study included the
zootechnical data, blood biochemistry and haematology. Consequently, the results obtained in that
study can support the safety of the additive with the new speciﬁcations in weaned piglets and minor
porcine species (except reproductive animals).
3.3. Efﬁcacy
Based on the results obtained in a pooling analysis of four efﬁcacy studies, the FEEDAP
Panel concluded, in 2017, that the additive has a potential to be efﬁcacious in weaned piglets (EFSA
FEEDAP Panel, 2017). The conclusions were extrapolated to minor porcine species (excluding
reproductive animals). The average enzyme activities (in U/kg feed) in those studies were 400 for
glucanase, 490 for xylanase and 1,400 for amylase (see Table 2).
The level of 500 mg/kg feed of the additive compliant with the new speciﬁcations would result in
the following enzyme activities in feed (U/kg feed): 450 U glucanase, 500 U xylanase and 1,500 U
amylase per kg feed.
The efﬁcacy of the additive had been demonstrated using feeds containing enzyme activities lower
than the ones that would be delivered by 500 mg Amylofeed®/kg feed compliant with the new
speciﬁcations. Therefore, the Panel concludes that the additive has a potential to be efﬁcacious in
weaned piglets and minor porcine species (excluding reproductive animals) at the level of 450 U
glucanase, 500 U xylanase and 1,500 U amylase per kg feed.
4. Conclusions
Amylofeed® compliant with the new speciﬁcations proposed by the applicant, 900 U glucanase/g
product, 1,000 U xylanase/g and 3,000 U amylase/g, is safe for the target species at the
recommended dose, safe for the consumers of food products derived from animals receiving the
6 Technical dossier FAD-2017-0063/Annex II.1.3.1.
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additive and for the environment. The additive is a potential skin and eye irritant and a potential skin
and respiratory sensitiser.
Amylofeed® has a potential to be efﬁcacious as a zootechnical additive in weaned piglets and minor
porcine species (excluding reproductive animals) at a level of 450 U glucanase, 500 U xylanase and
1,500 U amylase per kg feed.
Documentation provided to EFSA
1) Amylofeed® porcine species. October 2017. Submitted by Pintaluba S.A.
References
EFSA (European Food Safety Authority), 2008. Technical Guidance: extrapolation of data from major species to
minor species regarding the assessment of additives for use in animal nutrition. EFSA Journal 2008;6(9):803,
5 pp. https://doi.org/10.2903/j.efsa.2008.803
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2011. Technical
guidance: tolerance and efﬁcacy studies in target animals. EFSA Journal 2011;9(5):2175, 15 pp. https://doi.
org/10.2903/j.efsa.2011.2175
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2012. Guidance
for the preparation of dossiers for zootechnical additives. EFSA Journal 2012;10(1):2536, 19 pp. https://doi.
org/10.2903/j.efsa.2012.2536
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2013. Scientiﬁc
Opinion on the safety and efﬁcacy of Amylofeed® (endo-1,3(4)-beta-glucanase, endo-1,4-beta-xylanase and
alpha-amylase) as a feed additive for piglets and young minor porcine species. EFSA Journal 2013;11
(10):3430, 15 pp. https://doi.org/10.2903/j.efsa.2013.3430
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina
G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba
M, Lopez Alonso M, Lopez Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P,
Brantom P, Dierick NA and Anguita M, 2017. Scientiﬁc Opinion on the safety and efﬁcacy of Amylofeed® (endo-1,3
(4)-b-glucanase and endo-1,4-b-xylanase and a-amylase) as a feed additive for piglets and minor porcine species.
EFSA Journal 2017;15(6):4856, 11 pp. https://doi.org/10.2903/j.efsa.2017.4856
Abbreviations
CV coefﬁcient of variation
EC Enzyme Commission
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
Amylofeed® for weaned piglets and minor porcine species
www.efsa.europa.eu/efsajournal 7 EFSA Journal 2018;16(5):5271
